PEP Stock Crashes After Guidance Cut: Is GLP-1 the Death Knell for Cola Demand?
PepsiCo cut its full-year earnings outlook after Q3 2026 misses and mounting North American costs. PEP stock plunged as GLP-1 weight loss drugs structurally erode...
Enter code for secure login, or use password.
